Daiwa Securities Group
PMVP icon

Daiwa Securities Group’s PMV Pharmaceuticals PMVP Stock Holding History

Daiwa Securities Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-132
Closed -$1K – 1377
2023
Q3 		$1K Hold
132
– – ﹤0.01% 1270
2023
Q2 		$1K Hold
132
– – ﹤0.01% 1293
2023
Q1 		$1K Hold
132
– – ﹤0.01% 1276
2022
Q4 		$1K Hold
132
– – ﹤0.01% 1288
2022
Q3 		$2K Hold
132
– – ﹤0.01% 1244
2022
Q2 		$2K Hold
132
– – ﹤0.01% 1250
2022
Q1 		$3K Hold
132
– – ﹤0.01% 1223
2021
Q4 		$3K Buy
+132
New +$3.19K ﹤0.01% 1253

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Daiwa Securities Group's PMVP Position: Q4 2023 in Review

Daiwa Securities Group sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 132 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PMVP in Q4 2021 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • Daiwa Securities Group reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 132 PMV Pharmaceuticals shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's PMV Pharmaceuticals position peaked at $3K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.